Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
May 27, 2015
filing date -
Jun 7, 2006
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A method of treating depression includes locally administering a botulinum toxin subcutaneously to a face of a subject with depression, thereby treating the depression by reducing the occurrence of at least one symptom of depression. The botulinum toxin may be immunotype A or B. The toxin may be administered by injection to the forehead, scalp, face, and/or neck.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully